HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

H A Jinnah Selected Research

purine

4/2015Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.
1/2015Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants.
1/2015Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.
8/2014Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.
7/2014Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease.
1/2014Transcriptomic approach to Lesch-Nyhan disease.
12/2013Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.
1/2012Genotype-phenotype correlations in Lesch-Nyhan disease: moving beyond the gene.
5/2007A human neuronal tissue culture model for Lesch-Nyhan disease.
5/2006Delineation of the motor disorder of Lesch-Nyhan disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


H A Jinnah Research Topics

Disease

24Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
04/2015 - 04/2000
15Dystonia (Limb Dystonia)
02/2015 - 05/2000
6Hyperuricemia
01/2013 - 10/2000
4Nephrolithiasis
08/2014 - 03/2009
4Neuroblastoma
07/2014 - 05/2007
3Gouty Arthritis
08/2014 - 03/2009
3Channelopathies
02/2013 - 09/2002
3Nervous System Diseases (Neurological Disorders)
02/2013 - 10/2002
3Chorea (Rheumatic Chorea)
01/2008 - 09/2002
2Movement Disorders (Movement Disorder)
02/2015 - 09/2002
2Epilepsy (Aura)
01/2013 - 09/2002
2Atrophy
10/2012 - 06/2001
2Gout
04/2012 - 07/2009
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2011 - 06/2001
2Brain Ischemia (Cerebral Ischemia)
12/2008 - 10/2007
2Dyskinesias (Dyskinesia)
10/2002 - 09/2002
1Myoclonus (Nocturnal Myoclonus)
12/2014
1Renal Insufficiency (Renal Failure)
08/2014
1Metabolic Diseases (Metabolic Disease)
01/2014
1Pheochromocytoma
12/2013
1Dystonic Disorders (Writer's Cramp)
06/2013
1Inflammation
04/2013
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2013
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2013
1Carcinoma (Carcinomatosis)
03/2013
1Neoplasms (Cancer)
03/2013
1Alzheimer Disease (Alzheimer's Disease)
01/2011
1Parkinson Disease (Parkinson's Disease)
07/2009
1Neurologic Manifestations (Neurological Manifestations)
07/2009
1Tremor (Tremors)
02/2008
1Stroke (Strokes)
10/2007
1Vascular Diseases (Vascular Disease)
10/2007
1Gliosis
05/2007
1Mental Retardation (Idiocy)
05/2006
1Pain (Aches)
10/2002
1Fatigue
10/2002
1Seizures (Seizure)
09/2002
1Phenylketonurias (Phenylketonuria)
12/2001
1Huntington Disease (Huntington's Disease)
06/2001

Drug/Important Bio-Agent (IBA)

24Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
01/2015 - 04/2000
16purineIBA
04/2015 - 04/2000
7Uric Acid (Urate)IBA
08/2014 - 05/2006
6Dopamine (Intropin)FDA LinkGeneric
07/2014 - 02/2002
4TransferasesIBA
07/2009 - 02/2002
4GuanineIBA
07/2009 - 02/2002
4HypoxanthineIBA
07/2009 - 02/2002
3Ion Channels (Ion Channel)IBA
02/2013 - 10/2002
3Calcium Channels (Calcium Channel)IBA
09/2008 - 10/2002
3L-Type Calcium Channels (Dihydropyridine Receptor)IBA
01/2006 - 05/2000
2Codon (Codons)IBA
06/2013 - 10/2012
2Caffeine (No Doz)FDA LinkGeneric
02/2013 - 10/2002
2CalciumIBA
02/2013 - 09/2002
2Ethanol (Ethyl Alcohol)IBA
02/2013 - 10/2002
2Kainic Acid (Kainate)IBA
09/2008 - 09/2002
2Carbon MonoxideIBA
07/2005 - 05/2000
2FPL 64176IBA
11/2003 - 05/2000
2Methyl ester 1,4- dihydro- 2,6- dimethyl- 5- nitro- 4- (2- (trifluoromethyl)phenyl)- 3-Pyridinecarboxylic acidIBA
11/2003 - 05/2000
1ProteomeIBA
04/2015
1Tetrabenazine (Nitoman)FDA Link
12/2014
1Nerve Growth Factor (NGF)IBA
12/2013
1Thioguanine (Tioguanine)FDA Link
04/2013
16-Mercaptopurine (Mercaptopurine)FDA LinkGeneric
04/2013
1SelectinsIBA
04/2013
1Azathioprine (Imuran)FDA LinkGeneric
04/2013
1Adenylosuccinate LyaseIBA
01/2013
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2012
1PicrotoxinIBA
03/2012
1AMPA Receptors (AMPA Receptor)IBA
03/2012
1Glutamic Acid (Glutamate)FDA Link
03/2012
1Glutamate Receptors (Glutamate Receptor)IBA
03/2012
1Small Interfering RNA (siRNA)IBA
01/2011
1PresenilinsIBA
01/2011
1Messenger RNA (mRNA)IBA
08/2009
1Serotonin (5 Hydroxytryptamine)IBA
08/2009
1levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
07/2009
1N-Methylaspartate (NMDA)IBA
07/2009
1OligonucleotidesIBA
05/2007
15,6,7,8-tetrahydrobiopterin (tetrahydrobiopterin)FDA Link
01/2004
1Q-Type Calcium Channels (Q-Type Calcium Channel)IBA
10/2002
1domoic acidIBA
09/2002
1benzoquinoxalineIBA
09/2002
1Phenylalanine (L-Phenylalanine)FDA Link
12/2001
1Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA
12/2001
1Proteins (Proteins, Gene)IBA
06/2001
1polyglutamineIBA
06/2001
1atrophin-1IBA
06/2001
1FlunarizineIBA
05/2000
1Nimodipine (Modus)FDA LinkGeneric
05/2000
1Calcium Channel AgonistsIBA
05/2000
1Verapamil (Calan)FDA LinkGeneric
05/2000
1Diltiazem (Cardizem)FDA LinkGeneric
05/2000
1NitrendipineIBA
05/2000
1Nifedipine (Adalat)FDA LinkGeneric
05/2000
11,4-dihydropyridine (dihydropyridine)IBA
05/2000

Therapy/Procedure

3Therapeutics
01/2014 - 07/2005
2Deep Brain Stimulation
02/2015 - 11/2014
1Activities of Daily Living (ADL)
12/2014
1Drug Therapy (Chemotherapy)
03/2013
1Heterologous Transplantation (Xenotransplantation)
03/2013